• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Bill Novelli

Stay informed with Bill Novelli’s coverage and analysis for Coins2Day.

  • An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Patients, doctors and pharmacists across the US are struggling to get their hands on Eli Lilly & Co.’s powerful new obesity drug Zepbound, as demand for the weight-loss shot soars. Photographer: Shelby Knowles/Bloomberg via Getty ImagesCommentary

    Here’s the real reason Ozempic-like weight-loss drugs are so popular

    By Contributing Writer
  • LONDON, UNITED KINGDOM – 2023/05/13: A protester holds a placard during the Truth Be Told Demo while marching to Parliament Square in London. In June 2023, the government plans to expand the age group of those eligible to get vaccinated with Covid-19 vaccines to 6-month-olds. Anti-covid vaccine demonstrators were protesting against this plan pointing to the possible risks posed by Covid vaccines. Some relatives of those who allegedly died from the Covid-19 vaccines also joined the protest to seek justice for their loved ones. Currently, the government only allows 5-year-olds and above to get the Covid-19 vaccine. (Photo by Loredana Sangiuliano/SOPA Images/LightRocket via Getty Images)Commentary

    ‘An age of manufactured mistrust’: Here’s what rampant disinformation means for health, climate, and democracy

    By Digital Assets Editor
  • The mid adult woman helps her senior adult friend carefully enter her home.Commentary

    Millennials and Gen Xers might be the unluckiest caregivers in history. Here’s how their crisis is affecting every workplace

    By Industry Analyst
  • Calm business man standing above high-rise rooftop overlooking the city view at sunset.Commentary

    ESG is under attack–but Gen Zers and millennials are still looking for purpose and a paycheck

    By News Correspondent
  • WASHINGTON, DC – MAY 10: A mobile billboard calling out House Oversight Committee Republicans rolls past the U.S. Capitol on May 10, 2023 in Washington, DC. (Photo by Jemal Countess/Getty Images for Congressional Integrity Project)Commentary

    Climate change is the next frontier of America’s culture wars. Corporations are still doing the right thing–and hoping no one notices

    By News Correspondent
  • JERSEY CITY, NJ – MAY 25: A seagull flies in front of the skyline of Brooklyn, the Brooklyn Tower and the Statue of Liberty as the sun rises in New York City on May 25, 2023, as seen from Jersey City, New Jersey.  (Photo by Gary Hershorn/Getty Images)Commentary

    America can’t fulfill its purpose if we backslide on diversity, equity, and inclusion

    By Tech Reporter
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.